#######################
SET DOCUMENT Copyright   = "Copyright © 2018 Fraunhofer Institute SCAI, All rights reserved."
SET DOCUMENT Licenses    = "CC BY 4.0"
SET DOCUMENT ContactInfo = "charles.hoyt@scai.fraunhofer.de"

SET DOCUMENT Name        = "king2015"
SET DOCUMENT Version     = "1.0.0"
SET DOCUMENT Authors     = "Rana Aldisi"
SET DOCUMENT Description = "This file encodes the article Identification and Characterization of a G Protein-binding Cluster in alpha7 Nicotinic Acetylcholine Receptors by King et. al, 2015"

##############
# Namespaces #
##############

# Namespaces hosted on https://github.com/pharmacome/terminology
# --------------------------------------------------------------

# Namespaces hosted on https://github.com/pharmacome/terminology
# --------------------------------------------------------------
DEFINE NAMESPACE CHEBI          AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns"
DEFINE NAMESPACE DRUGBANK       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns"
DEFINE NAMESPACE ECCODE         AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns"
# DEFINE NAMESPACE FB           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/80171ae62cf43aa1fc8a6c326b94537ab342458c/external/fb-names.belns"
DEFINE NAMESPACE HBP            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/cf4d8bb88754f036b943b4d94ad96e103dcb7149/export/hbp-names.belns"
DEFINE NAMESPACE HGNC           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns"
DEFINE NAMESPACE HGNCGENEFAMILY AS URL "https://raw.githubusercontent.com/pharmacome/terminology/73688d6dc24e309fca59a1340dc9ee971e9f3baa/external/hgnc.genefamily-names.belns"
DEFINE NAMESPACE GO             AS URL "https://raw.githubusercontent.com/pharmacome/terminology/73688d6dc24e309fca59a1340dc9ee971e9f3baa/external/go-names.belns"
DEFINE NAMESPACE INTERPRO       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/interpro-names.belns"
DEFINE NAMESPACE MESH           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/01c9daa61012b37dd0a1bc962521ba51a15b38f1/external/mesh-names.belns"
DEFINE NAMESPACE MGI            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns"
DEFINE NAMESPACE MIRBASE        AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/mirbase-names.belns"
DEFINE NAMESPACE NCBIGENE       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns"
DEFINE NAMESPACE PFAM           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/pfam-names.belns"
DEFINE NAMESPACE RGD            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/rgd-names.belns"

# Namespaces hosted on https://github.com/sorgerlab/famplex
# ---------------------------------------------------------
DEFINE NAMESPACE FPLX           AS URL "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns"

# Namespaces hosted on https://arty.scai.fraunhofer.de/artifactory/bel/namespace
# ------------------------------------------------------------------------------
DEFINE NAMESPACE CTO            AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/clinical-trial-ontology/clinical-trial-ontology-1.0.0.belns"
DEFINE NAMESPACE DO             AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20170725.belns"
DEFINE NAMESPACE HP             AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns"
DEFINE NAMESPACE SCOMP          AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-named-complexes/selventa-named-complexes-20170725.belns"
DEFINE NAMESPACE SFAM           AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-protein-families/selventa-protein-families-20170725.belns"

# Namespaces defined with regular expressions
# -------------------------------------------
DEFINE NAMESPACE DBSNP          AS PATTERN "rs[0-9]+"
DEFINE NAMESPACE TAXONOMY       AS PATTERN "^\d+$"
DEFINE NAMESPACE UNIPROT        AS PATTERN "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\.\d+)?$"
DEFINE NAMESPACE PUBCHEM        AS PATTERN "^\d+$"

###############
# Annotations #
###############

# Annotations defined with regular expressions
# --------------------------------------------
DEFINE ANNOTATION Species       AS PATTERN "^\d+$"

# Annotations hosted on https://arty.scai.fraunhofer.de/artifactory/bel/annotation
# --------------------------------------------------------------------------------
DEFINE ANNOTATION Anatomy       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno"
DEFINE ANNOTATION CellLine      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno"
DEFINE ANNOTATION CellStructure AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno"
DEFINE ANNOTATION Cell          AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno"
DEFINE ANNOTATION Confidence    AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno"
DEFINE ANNOTATION Disease       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno"
DEFINE ANNOTATION Gender        AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno"
DEFINE ANNOTATION MeSHAnatomy   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno"
DEFINE ANNOTATION MeSHDisease   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
DEFINE ANNOTATION Subgraph      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno"
DEFINE ANNOTATION TextLocation  AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"

##############
# Statements #
##############

SET Citation = {"PubMed", "26088141"}

SET Evidence = "As shown in Fig. 1A, α7 nAChRs were found in association with
Gαs, Gαq, and Gαi proteins within the hippocampus and prefrontal cortex.
Striatal fractions suggest α7 interaction with Gαq and Gαi subunits (Fig. 1A)."

SET MeSHAnatomy = {"Hippocampus", "Prefrontal Cortex"}

p(HGNC:GNAS) -> complex(p(HGNC:GNAS), p(HGNC:CHRNA7))
p(HGNC:GNAQ) -> complex(p(HGNC:GNAQ), p(HGNC:CHRNA7))
p(HGNC:GNAI1) -> complex(p(HGNC:GNAI1), p(HGNC:CHRNA7))
p(HGNC:GNAI2) -> complex(p(HGNC:GNAI2), p(HGNC:CHRNA7))

UNSET MeSHAnatomy

SET MeSHAnatomy = "Corpus Striatum"

p(HGNC:GNAQ) -> complex(p(HGNC:GNAQ), p(HGNC:CHRNA7))
p(HGNC:GNAI1) -> complex(p(HGNC:GNAI1), p(HGNC:CHRNA7))
p(HGNC:GNAI2) -> complex(p(HGNC:GNAI2), p(HGNC:CHRNA7))

UNSET MeSHAnatomy

SET Evidence = "An association between α7 nAChRs and Gβ was observed in the
prefrontal cortex and hippocampus, whereas little to no detection of Gαo was
seen in the adult brain (Fig. 1A)."

SET MeSHAnatomy = {"Prefrontal Cortex", "Hippocampus"}

p(HGNCGENEFAMILY:"G protein subunits beta") -> complex(p(FPLX:"G_protein"), p(HGNC:CHRNA7))

UNSET MeSHAnatomy

SET Evidence = "Gel lanes of the BgtxC were divided into 3 molecular mass
fractions: F1, 190-90 kDa; F2, 89-45 kDa; and F3, 44-15 kDa (Fig. 1C). Proteomic
analysis was performed on the individual fractions using tryptic in-gel
digestion followed by high-performance LC-ESI. A cohort of G proteins was
identified in the F2 and F3 fractions (Fig. 1D). These G proteins were not
detected in BgtxC from α7−/− mice (data not shown)."

composite(p(HGNC:CHRNA7), p(MESH:"Heterotrimeric GTP-Binding Proteins"), p(HBP:"alpha-Bungarotoxin")) -> complex(p(MESH:"Heterotrimeric GTP-Binding Proteins"), a(HBP:"alpha-Bungarotoxin"))

SET Evidence = "Sequence alignment of mammalian nAChRs revealed a conservation
of residues at the GPBC site in the M3-M4 loop (Fig. 2A). Based on amino acid
similarity we found that α7 nAChRs possess 88% homology with the GyR1 at the
GPBC (Fig. 2A)."
# Typo here in GyR1 , should be GlyR1 which means Glycine Receptor 1 (GLRA1)

p(HBP:"GPBC, alpha-7 nAChR") orthologous p(HBP:"GPBC, Glycine Receptor 1")

SET Evidence = "The findings
confirm that the mutation in α7345–348A does not interfere with the trafficking
or expression of the nAChR."

p(HGNC:CHRNA7) -> bp(HBP:"nAChR assembly")
p(HGNC:CHRNA7, var("p.345A"), var("p.346A"), var("p.347A"), var("p.348A")) -> bp(HBP:"nAChR assembly")

SET Evidence = "Western blot analysis confirms that transfection of α7 nAChRs
augments total α7 subunit expression in PC12 cells, which express endogenous α7
nAChRs. Transfection with α7 (α7+) increased the immunoreactive α7 signal by over
60% from endogenous mock-transfected control cells, whereas transfection with the
mutant α7345–348A increased the total α7 signal by 48% over the endogenous α7
from control cells (Fig. 3A)."

SET MeSHAnatomy = "PC12 Cells"

p(HGNC:CHRNA7) -> p(HGNC:CHRNA7)
p(HGNC:CHRNA7, var("p.345A"), var("p.346A"), var("p.347A"), var("p.348A")) -> p(HGNC:CHRNA7)

UNSET MeSHAnatomy

SET Evidence = "Studies in N2a cells indicate that transfection with α7345–348A
yields a similar α7 nAChR expression as the wild-type (α7) and supports the
finding that mutation at the GPBC does not impact the synthesis of the nAChR in
cells."

SET CellLine = "Neuro-2a cell"

g(HGNC:CHRNA7, var("p.345A"), var("p.346A"), var("p.347A"), var("p.348A")) cnc p(HGNC:CHRNA7, var("p.345A"), var("p.346A"), var("p.347A"), var("p.348A"))

UNSET CellLine

SET Evidence = "As shown in Fig. 3A, coupling between Gαq and α7 nAChRs was
virtually abolished by expression of α7345–348A. A noticeable loss in Gαq
(−62.18%) and Gβγ (−20.03%) expression within the α7 nAChR complex IP was seen
in cells transfected with α7345–348A (Fig. 3A)."

p(HGNC:CHRNA7, var("p.345A"), var("p.346A"), var("p.347A"), var("p.348A")) =| complex(p(HGNC:CHRNA7, var("p.345A"), var("p.346A"), var("p.347A"), var("p.348A")), p(HGNC:GNAQ))
p(HGNC:CHRNA7, var("p.345A"), var("p.346A"), var("p.347A"), var("p.348A")) =| complex(p(HGNC:CHRNA7, var("p.345A"), var("p.346A"), var("p.347A"), var("p.348A")), p(FPLX:"G_beta") ,p(FPLX:"G_gamma"))

SET Evidence = "An increase in G protein association within the α7 complex was
observed in α7+ cells (Gαq +16.71%; Gβγ +19.90%) (Fig. 3A). Similar findings in
transfected N2a cells indicate a loss in G protein association within the α7
complex when α7345–348A nAChRs are expressed (Fig. 3B). "

p(HGNC:CHRNA7) -> complex(p(HGNC:CHRNA7), p(HGNC:GNAQ))
p(HGNC:CHRNA7) -> complex(p(HGNC:CHRNA7), p(FPLX:"G_beta") ,p(FPLX:"G_gamma"))
p(HGNC:CHRNA7, var("p.345A"), var("p.346A"), var("p.347A"), var("p.348A")) =| complex(p(HGNC:CHRNA7, var("p.345A"), var("p.346A"), var("p.347A"), var("p.348A")), p(HGNC:GNAQ))
p(HGNC:CHRNA7, var("p.345A"), var("p.346A"), var("p.347A"), var("p.348A")) =| complex(p(HGNC:CHRNA7, var("p.345A"), var("p.346A"), var("p.347A"), var("p.348A")), p(FPLX:"G_beta") ,p(FPLX:"G_gamma"))

SET Evidence = "The data complements earlier findings on the ability of
α7345–348A to function as a dominant negative blocker of G protein coupling in
PC12 cells, and suggests that the GPBC directs nAChR association with Gαq and Gβγ."

p(HGNC:CHRNA7, var("p.345A"), var("p.346A"), var("p.347A"), var("p.348A")) =| complex(p(HGNC:CHRNA7, var("p.345A"), var("p.346A"), var("p.347A"), var("p.348A")), p(HGNC:GNAQ))
p(HGNC:CHRNA7, var("p.345A"), var("p.346A"), var("p.347A"), var("p.348A")) =| complex(p(HGNC:CHRNA7, var("p.345A"), var("p.346A"), var("p.347A"), var("p.348A")), p(FPLX:"G_beta") ,p(FPLX:"G_gamma"))

SET Evidence = "
In α7+ cells, choline application resulted in a calcium signal that peaked at
1050% ΔF/Fθ (±176.4%) in the neurite. Calcium transients in the GC were found to
last for ∼1.6 s in both α7 and α7+ cells peaking at 1396% (±154.4%) and 1316%
(±146.9%) ΔF/Fθ, relatively (Fig. 4, A and B)."

SET MeSHAnatomy = "Neurites"


composite(p(HGNC:CHRNA7), a(CHEBI:choline)) -> a(CHEBI:"calcium(2+)")

UNSET MeSHAnatomy

SET Evidence = "PC12 cells transfected with α7345–348A showed a reduction in
choline-mediated calcium responses."

SET MeSHAnatomy = "PC12 Cells"

p(HGNC:CHRNA7, var("p.345A"), var("p.346A"), var("p.347A"), var("p.348A")) -| act(a(CHEBI:choline))
act(a(CHEBI:choline)) -> a(CHEBI:"calcium(2+)")
p(HGNC:CHRNA7, var("p.345A"), var("p.346A"), var("p.347A"), var("p.348A")) -| a(CHEBI:"calcium(2+)")

UNSET MeSHAnatomy

SET Evidence = "Most notably, in the GC, the calcium peak values were
significantly lower in α7345–348A-transfected cells compared with α7 cells after
Tukey's HSD post hoc comparisons (peak: 741 ± 159.8% ΔF/Fθ, p = 0.006). This
represents a 46.92% reduction from the α7 baseline calcium response (Fig. 4, A
and B). This reduction approached significance in the neurite of α7345–348A cells
(peak: 561 ± 124.9% ΔF/Fθ) (Fig. 4, A and B)"

SET MeSHAnatomy = "Neurites"

composite(p(HGNC:CHRNA7, var("p.345A"), var("p.346A"), var("p.347A"), var("p.348A")), a(CHEBI:choline)) -| a(CHEBI:"calcium(2+)")

UNSET MeSHAnatomy

SET Evidence = "In N2a cells α7345–348A nAChR expression fostered a weak calcium
response to (10 mM) choline, whereas expression of α7 nAChRs correlated with
noticeable choline-induced calcium transient. Imaging studies in N2a cells
expressing α7345–348A nAChRs indicate a significantly lowered calcium signal peak
to choline (333.4% ΔF/Fθ ± 35.7%) when compared with N2a cells that express the
α7nAChR (peak: 581% ΔF/Fθ ± 122.7%; p = 0.04) (Fig. 4, D and E)."

SET CellLine = "Neuro-2a cell"

composite(p(HGNC:CHRNA7), a(CHEBI:choline)) -> a(CHEBI:"calcium(2+)")
composite(p(HGNC:CHRNA7, var("p.345A"), var("p.346A"), var("p.347A"), var("p.348A")), a(CHEBI:choline)) -| a(CHEBI:"calcium(2+)")

UNSET CellLine

SET Evidence = "These findings in N2a cells are consistent with data from PC12 cells
and suggest that α7345–348A nAChR expression impairs nAChR calcium signaling."

p(HGNC:CHRNA7, var("p.345A"), var("p.346A"), var("p.347A"), var("p.348A")) -| bp(GO:"calcium-mediated signaling")

SET Evidence = "SP pretreatment did not significantly alter calcium peaks in
α7345–348A nAChR expressing cells, showing a small (−31.24%) reduction in calcium
responses relative to the α7345–348A baseline measure (p > 0.05)."
#SP =D-[7,9,10-Trp]substance P =  GP Antagonist-2A peptide
a(MESH:"GP Antagonist-2A peptide") cnc a(CHEBI:"calcium(2+)")
a(MESH:"GP Antagonist-2A peptide") cnc act(p(HGNC:CHRNA7, var("p.345A"), var("p.346A"), var("p.347A"), var("p.348A")))

SET Evidence = "Because α7345–348A-
transfected cells did not show any responsiveness to SP, these findings suggest
this receptor mutant is not functionally coupled to Gαq."

p(HGNC:CHRNA7, var("p.345A"), var("p.346A"), var("p.347A"), var("p.348A")) =| complex(p(HGNC:CHRNA7, var("p.345A"), var("p.346A"), var("p.347A"), var("p.348A")), p(HGNC:GNAQ))

SET Evidence = "As shown in Fig. 5, A–C, barium replacement had little to no
effect on the peak and total calcium transient observed in α7 (peak: 1474.83%
ΔF/Fθ ± 162.00%; AUC: 693.5% ΔF/Fθ2 × s ± 154.15%) and α7345–348A expressing
cells (peak: 794% ΔF/Fθ ± 81.36%; AUC: 543.5% ΔF/Fθ2 × s ± 89.59%)."

a(MESH:Barium) cnc bp(GO:"calcium-mediated signaling")
a(MESH:Barium) cnc act(p(HGNC:CHRNA7, var("p.345A"), var("p.346A"), var("p.347A"), var("p.348A")))
a(MESH:Barium) cnc act(p(HGNC:CHRNA7))

SET Evidence = "As shown in Fig. 5, A–C, nifedipine was found to decrease the
peak calcium response to choline in PC12 cells (peak: 795.00% ΔF/Fθ ± 107.1%) by
56.94% (p = 0.003), whereas prolonging the duration of the choline-induced calcium
transient (AUC: 749.50% ΔF/Fθ2 × s ± 64.02%) in the same cell."

SET MeSHAnatomy = "PC12 Cells"

a(CHEBI:nifedipine) -| act(a(CHEBI:choline))
a(CHEBI:nifedipine) -| a(CHEBI:"calcium(2+)")
a(CHEBI:nifedipine) -> bp(GO:"calcium-mediated signaling")

UNSET MeSHAnatomy

SET Evidence = "In α7345–348A nAChR expressing cells, nifedipine had no effect on
the peak or the duration of the calcium transient (peak: 957.00% ΔF/Fθ ± 252.2%;
AUC: 333.33% ΔF/Fθ2 × s ± 91.53%) relative to choline treatment alone (Fig. 5,
A–C). The findings suggest that choline-induced calcium responses in PC12
cells involve the activity of VGCC (37, 38)."

a(CHEBI:nifedipine) cnc act(p(HGNC:CHRNA7, var("p.345A"), var("p.346A"), var("p.347A"), var("p.348A")))
a(CHEBI:nifedipine) cnc bp(GO:"calcium-mediated signaling")
act(a(CHEBI:choline)) -- act(a(MESH:"Calcium Channels"))
a(CHEBI:"calcium(2+)") -- act(a(MESH:"Calcium Channels"))

SET Evidence = "Treatment of PC12 cells with 10 mM choline was associated with a
translocation of PH-mCherry from the cell surface as determined by the presence
of the fluorescence signal within 1 μm of the edge of the cell into the cytosol
of the GC (Fig. 6, A and B). Pre-treatment of cells with SP abolished this
translocation (Fig. 6B)."

SET MeSHAnatomy = {"PC12 Cells","Cytosol"}

a(CHEBI:choline) -- bp(MESH:"Pleckstrin Homology Domains")
a(MESH:"GP Antagonist-2A peptide") -| bp(MESH:"Pleckstrin Homology Domains")

UNSET MeSHAnatomy

SET Evidence = "In PC12 cells expressing α7345–348A nAChRs choline had a weak
effect on PH-mCherry translocation relative to empty plasmid-transfected controls.
Expression α7345–348A nAChRs was surprisingly associated with strong levels of
PH-mCherry at the cell surface in the absence of drug treatment (Fig. 6B)."

SET MeSHAnatomy = {"PC12 Cells","Cytosol"}

p(HGNC:CHRNA7, var("p.345A"), var("p.346A"), var("p.347A"), var("p.348A")) -| bp(MESH:"Pleckstrin Homology Domains")

SET MeSHAnatomy = "Cell Membrane"

p(HGNC:CHRNA7, var("p.345A"), var("p.346A"), var("p.347A"), var("p.348A")) -| bp(MESH:"Pleckstrin Homology Domains")

UNSET MeSHAnatomy

SET Evidence = "Sequential imaging of PH-mCherry and GCaMP5G confirms that choline
promotes a rise in intracellular calcium and PH-mCherry translocation in the same
cellular compartment (Fig. 6, B and C). Cytoplasmic translocation of PH-mCherry
occurred on a slower time scale (40 s after choline application) than peak calcium
responses (∼1 s after choline application). These kinetics are consistent with the
translocation of the PH domain sensor in the cell (20, 29)."

SET MeSHAnatomy = "Cytosol"

a(CHEBI:choline) -> bp(MESH:"Pleckstrin Homology Domains")

SET MeSHAnatomy = "Intracellular Space"

a(CHEBI:choline) -> bp(MESH:"Pleckstrin Homology Domains")

UNSET MeSHAnatomy

SET Evidence = "We confirmed the involvement of IP3Rs in choline-induced calcium
transients at the GC of PC12 cells. Cells were preincubated with the IP3R blocker
xestospongin C (1 μM) prior to imaging. As shown in Fig. 7, A–C, pretreatment with
xestospongin C reduced the α7 nAChR calcium response peak by 46.82% in α7 cells
(peak: 1308.43% ΔF/Fθ ± −238.13%; + xestospongin C = 695.80% ΔF/Fθ ± 101.46%)."

SET MeSHAnatomy = "PC12 Cells"

a(MESH:"xestospongin C") -| act(p(HGNC:CHRNA7))
a(MESH:"xestospongin C") -| bp(GO:"calcium-mediated signaling")

UNSET MeSHAnatomy

SET Evidence = "Xestospongin C treatment did not impact the calcium peak
(628.87% ΔF/Fθ ± 69.43%) or total calcium transient (AUC: 443.86% ΔF/Fθ2 ×
s ± 54.72%; + xestospongin C = 340.39% ΔF/Fθ2 × s ± 96.99%) in α7345–348A
expressing cells (α7 to α7 + xestospongin C, p = 0.017; α7 to α7345–348A,
p = 0.013; α7 to α7345-348A + xestospongin C, p = 0.017) (Fig. 7, B and C).
The data underscores the inability of α7345–348A nAChRs to activate
intracellular calcium via IP3Rs (18)."

a(MESH:"xestospongin C") -| act(p(HGNC:CHRNA7, var("p.345A"), var("p.346A"), var("p.347A"), var("p.348A")))
p(HGNC:CHRNA7, var("p.345A"), var("p.346A"), var("p.347A"), var("p.348A")) -| act(a(CHEBI:"calcium(2+)", loc(GO:intracellular)))

SET Evidence = "As shown in Fig. 8, A and B, IP of the α7 using the C-20 antibody
suggests that choline application attenuates G protein binding with the nAChR.
Choline treatment resulted in a 56% reduction in Gαq and 47% reduction in Gβ
association within the α7 nAChR complex (Fig. 8B). "

a(CHEBI:choline) -| complex(p(HGNC:CHRNA7), p(FPLX:"G_protein"))
a(CHEBI:choline) -| complex(p(HGNC:CHRNA7), p(HGNC:GNAQ))
a(CHEBI:choline) -| complex(p(HGNC:CHRNA7), p(HGNCGENEFAMILY:"G protein subunits beta"))
